{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:15:41Z","timestamp":1793301341148,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["01-10025\/0008288"],"award-info":[{"award-number":["01-10025\/0008288"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_207705"],"award-info":[{"award-number":["310030_207705"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["KFS-5979-08-2023"],"award-info":[{"award-number":["KFS-5979-08-2023"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["101034170"],"award-info":[{"award-number":["101034170"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jaip.2025.11.016","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:14:37Z","timestamp":1763828077000},"page":"30-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Management of Mastocytosis and Mast Cell Activation in Children"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0379-5366","authenticated-orcid":false,"given":"Melody C.","family":"Carter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Alvarez-Twose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Renke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Morales-Cabeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Caligaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.11.016_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-025-00611-8","article-title":"Mastocytosis","volume":"11","author":"Akin","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaip.2025.11.016_bib2","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.3390\/ijms22052586","article-title":"Molecular background, clinical features and management of pediatric mastocytosis: status 2021","volume":"22","author":"Lange","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2025.11.016_bib3","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.jaip.2020.12.019","article-title":"Criteria for the regression of pediatric mastocytosis: a long-term follow-up","volume":"9","author":"Polivka","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.11.016_bib4","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jaci.2015.05.034","article-title":"Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis","volume":"136","author":"Wiechers","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib5","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.jid.2020.12.030","article-title":"Clinical impact of skin lesions in mastocytosis: a multicenter study of the European Competence Network on Mastocytosis","volume":"141","author":"Aberer","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaci.2015.08.034","article-title":"Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology","volume":"137","author":"Hartmann","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.11.016_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/bjh.20214","article-title":"Prevalence of myeloid gene alterations in paediatric cutaneous and systemic mastocytosis","volume":"207","author":"Sun","year":"2025","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2025.11.016_bib9","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","article-title":"Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations","volume":"130","author":"Bodemer","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7150\/thno.51872","article-title":"Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis","volume":"11","author":"Kluin-Nelemans","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jaip.2025.11.016_bib11","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2005.06.060","article-title":"Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis","volume":"129","author":"Hartmann","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2025.11.016_bib12","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.jaip.2020.12.049","article-title":"Detection of the germline KIT S476I mutation in a kindred with familial mastocytosis associated with gastrointestinal stromal tumors","volume":"9","author":"Peters","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.11.016_bib13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bjd.13567","article-title":"Paediatric mastocytosis: a systematic review of 1747 cases","volume":"172","author":"Meni","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib14","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.jaip.2023.02.021","article-title":"European Competence Network on Mastocytosis (ECNM): 20-year jubilee, updates, and future perspectives","volume":"11","author":"Valent","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.11.016_bib15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaip.2025.11.016_bib16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/bjd.16795","article-title":"Pediatric mastocytosis: long term follow up of 53 patients with whole sequencing of KIT. A prospective study","volume":"179","author":"Meni","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/diagnostics14020161","article-title":"Challenges in the diagnosis of cutaneous mastocytosis","volume":"14","author":"Brockow","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jaip.2025.11.016_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/cea.14608","article-title":"How to recognise mastocytosis?","volume":"55","author":"Grattan","year":"2025","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.11.016_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1468-3083.2011.04365.x","article-title":"Clinical aspects of paediatric mastocytosis: a review of 101 cases","volume":"27","author":"Lange","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.11.016_bib20","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.3390\/diagnostics13233583","article-title":"Current challenges in the diagnosis of pediatric cutaneous mastocytosis","volume":"13","author":"Lugowska-Umer","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jaip.2025.11.016_bib21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1182\/blood-2013-11-538355","article-title":"Darier\u2019s sign in mastocytosis","volume":"123","author":"Galen","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2025.11.016_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40257-025-00947-7","article-title":"Mastocytosis in the skin: approach to diagnosis, evaluation, and management in adult and pediatric patients","volume":"26","author":"Madigan","year":"2025","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/pde.12291","article-title":"Severity of cutaneous findings predict the presence of systemic symptoms in pediatric maculopapular cutaneous mastocytosis","volume":"31","author":"Barnes","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib24","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.3390\/ijms22052684","article-title":"Mediator-related symptoms and anaphylaxis in children with mastocytosis","volume":"22","author":"Brockow","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2025.11.016_bib25","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jaci.2015.04.024","article-title":"Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis","volume":"136","author":"Carter","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1067\/mjd.2003.98","article-title":"Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology","volume":"48","author":"Brockow","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib27","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.iac.2023.04.001","article-title":"Pediatric and hereditary mastocytosis","volume":"43","author":"Renke","year":"2023","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2025.11.016_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/bjd\/ljaf141","article-title":"Childhood mastocytosis: challenges and potential shortfalls in current disease classification","volume":"193","author":"Torrelo","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1398-9995.2012.02812.x","article-title":"Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis","volume":"67","author":"Alvarez-Twose","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.11.016_bib30","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/all.12013","article-title":"Extensive blistering is a predictor for severe complications in children with mastocytosis","volume":"67","author":"Brockow","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.11.016_bib31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.iac.2018.04.009","article-title":"Pediatric expression of mast cell activation disorders","volume":"38","author":"Broesby-Olsen","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2025.11.016_bib32","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/ijd.15542","article-title":"Natural evolution in pediatric cutaneous mastocytosis: 10-year follow-up","volume":"60","author":"Czarny","year":"2021","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib33","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/jdv.18143","article-title":"Validation of dermatopathological criteria to diagnose cutaneous lesions of mastocytosis: importance of KIT D816V mutation analysis","volume":"36","author":"Gebhard","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.11.016_bib34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/1573396315666181120163952","article-title":"Childhood solitary cutaneous mastocytoma: clinical manifestations, diagnosis, evaluation, and management","volume":"15","author":"Leung","year":"2019","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/j.jaip.2025.11.016_bib35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000243808","article-title":"Clinical aspects of diffuse cutaneous mastocytosis in children: two variants","volume":"219","author":"Heide","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2025.11.016_bib36","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamadermatol.2025.1488","article-title":"Characteristics and therapeutic strategies for diffuse cutaneous mastocytosis","volume":"161","author":"Pernea","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib37","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3390\/ijms25031401","article-title":"Diffuse cutaneous mastocytosis: a current understanding of a rare disease","volume":"25","author":"Rydz","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2025.11.016_bib38","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/j.1468-3083.2011.04350.x","article-title":"Diffuse cutaneous mastocytosis: analysis of 10 cases and a brief review of the literature","volume":"26","author":"Lange","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.11.016_bib39","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1016\/j.jaip.2023.08.019","article-title":"A familial case of diffuse cutaneous mastocytosis","volume":"11","author":"Wangberg","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.11.016_bib40","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1111\/pde.13651","article-title":"Diffuse cutaneous mastocytosis: case report and literature review","volume":"35","author":"Hosking","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib41","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/pde.13801","article-title":"Management of a neonate with diffuse cutaneous mastocytosis: case report and literature review","volume":"36","author":"Jenkinson","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib42","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3390\/genes14112021","article-title":"When mast cells run amok: a comprehensive review and case study on severe neonatal diffuse cutaneous mastocytosis","volume":"14","author":"Olteanu","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jaip.2025.11.016_bib43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000089026","article-title":"Neonatal mastocytosis with pachydermic bullous skin without c-Kit 816 mutation","volume":"212","author":"Walker","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2025.11.016_bib44","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1097\/MPH.0000000000001271","article-title":"c-KIT-positive fatal diffuse cutaneous mastocytosis with systemic manifestations in a neonate","volume":"41","author":"Chaudhary","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaip.2025.11.016_bib45","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaci.2015.05.008","article-title":"Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis","volume":"137","author":"Alvarez-Twose","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib46","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaci.2013.06.016","article-title":"Anaphylaxis treated in a Canadian pediatric hospital: incidence, clinical characteristics, triggers, and management","volume":"132","author":"Ben-Shoshan","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib47","doi-asserted-by":"crossref","first-page":"e4934","DOI":"10.1097\/MD.0000000000004934","article-title":"Well-differentiated systemic mastocytosis showed excellent clinical response to imatinib in the absence of known molecular genetic abnormalities: a case report","volume":"95","author":"Huang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2025.11.016_bib48","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2222.2011.03954.x","article-title":"Anaphylaxis and reactions to foods in children--a population-based case study of emergency department visits","volume":"42","author":"Vetander","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.11.016_bib49","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)","volume":"37","author":"Gonzalez de Olano","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.11.016_bib50","doi-asserted-by":"crossref","first-page":"e1545","DOI":"10.1542\/peds.2012-2585","article-title":"Galactose-alpha-1,3-galactose and delayed anaphylaxis, angioedema, and urticaria in children","volume":"131","author":"Kennedy","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2025.11.016_bib51","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/bjd.14004","article-title":"Clinical features and course of cutaneous mastocytosis in 133 children","volume":"174","author":"Schena","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib52","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaci.2012.10.052","article-title":"Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis","volume":"131","author":"Alvarez-Twose","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib53","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2014.11.035","article-title":"Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels","volume":"136","author":"Zanotti","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib55","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/all.12098","article-title":"Importance of serum basal tryptase levels in children with insect venom allergy","volume":"68","author":"Yavuz","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.11.016_bib56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4274\/jpr.galenos.2019.96720","article-title":"Unexpected reactions to vaccines in children with mastocytosis: an observational study","volume":"7","author":"Abuhay","year":"2020","journal-title":"J Pediatr Res"},{"key":"10.1016\/j.jaip.2025.11.016_bib57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/pai.12647","article-title":"Evaluation of vaccination safety in children with mastocytosis","volume":"28","author":"Parente","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib58","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaip.2012.08.008","article-title":"Generalized bullous eruption after routine vaccination in a child with diffuse cutaneous mastocytosis","volume":"1","author":"Bankova","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.11.016_bib59","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jaip.2018.11.046","article-title":"Blisters, vaccines, and mast cells: a difficult case of diffuse cutaneous mastocytosis","volume":"7","author":"Gupta","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.11.016_bib60","first-page":"37","article-title":"Solitary mastocytoma arising at a hepatitis B vaccination site","volume":"63","author":"Poulton","year":"1999","journal-title":"Cutis"},{"key":"10.1016\/j.jaip.2025.11.016_bib61","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000436969","article-title":"Management of anesthesia in adult and pediatric mastocytosis: a study of the Spanish Network on Mastocytosis (REMA) based on 726 anesthetic procedures","volume":"167","author":"Matito","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib62","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1213\/ane.0b013e31817e6d7c","article-title":"Pediatric mastocytosis: routine anesthetic management for a complex disease","volume":"107","author":"Carter","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaip.2025.11.016_bib63","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.mph.0000212950.12856.d4","article-title":"Mast cell disease: surgical and anesthetic implications","volume":"28","author":"Damodar","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaip.2025.11.016_bib64","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/BF03014363","article-title":"Cutaneous mastocytosis in children: anaesthetic considerations","volume":"34","author":"James","year":"1987","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jaip.2025.11.016_bib65","doi-asserted-by":"crossref","first-page":"e12132","DOI":"10.1002\/clt2.12132","article-title":"Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features","volume":"12","author":"Rama","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2025.11.016_bib66","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","article-title":"A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis","volume":"141","author":"Carter","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib67","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ajh.23931","article-title":"Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management","volume":"90","author":"Pardanani","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaip.2025.11.016_bib68","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.jaip.2025.11.016_bib69","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1097\/MPH.0b013e3182329b80","article-title":"Myelomastocytic leukemia with t(8;21) in a 3-year-old child","volume":"33","author":"Intzes","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaip.2025.11.016_bib70","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/pbc.23026","article-title":"Systemic mastocytosis in a child with t(8;21) acute myeloid leukemia","volume":"57","author":"Mahadeo","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaip.2025.11.016_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26282","article-title":"A variant c-KIT mutation, D816H, fundamental to the sequential development of an ovarian mixed germ cell tumor and systemic mastocytosis with chronic myelomonocytic leukemia","volume":"64","author":"Mitchell","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaip.2025.11.016_bib72","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13000-018-0691-2","article-title":"De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child","volume":"13","author":"Zheng","year":"2018","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jaip.2025.11.016_bib73","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00198-019-04918-7","article-title":"Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome","volume":"30","author":"Degboe","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jaip.2025.11.016_bib74","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.jaip.2023.06.045","article-title":"Vertebral fracture in a 7-year-old boy with indolent systemic mastocytosis","volume":"11","author":"Bocca-Tjeertes","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.11.016_bib75","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.iac.2023.04.011","article-title":"World Health Organization Classification and Diagnosis of Mastocytosis: Update 2023 and Future Perspectives","volume":"43","author":"Valent","year":"2023","journal-title":"Immunol Allegy Clin North Am"},{"key":"10.1016\/j.jaip.2025.11.016_bib76","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2025.11.016_bib77","doi-asserted-by":"crossref","first-page":"68950","DOI":"10.18632\/oncotarget.10711","article-title":"Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature","volume":"8","author":"Alvarez-Twose","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaip.2025.11.016_bib78","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejim.2022.01.004","article-title":"Darier\u2019s sign","volume":"97","author":"Krecak","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jaip.2025.11.016_bib79","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.jaip.2023.08.008","article-title":"The normal range of baseline tryptase should be 1 to 15 ng\/mL and covers healthy individuals with HalphaT","volume":"11","author":"Valent","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.11.016_bib80","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5114\/ada.2017.69308","article-title":"The role of serum tryptase in the diagnosis and monitoring of pediatric mastocytosis: a single-center experience","volume":"34","author":"Lange","year":"2017","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jaip.2025.11.016_bib81","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.3390\/diagnostics13213307","article-title":"A puzzling mast cell trilogy: anaphylaxis, MCAS, and mastocytosis","volume":"13","author":"Gulen","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jaip.2025.11.016_bib82","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/cea.14264","article-title":"Clonal mast cell disorders and hereditary alpha-tryptasemia as risk factors for anaphylaxis","volume":"53","author":"Kacar","year":"2023","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.11.016_bib83","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaip.2025.11.016_bib84","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/bjh.15624","article-title":"Detection of KIT D816V in peripheral blood of children with manifestations of cutaneous mastocytosis suggests systemic disease","volume":"183","author":"Carter","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2025.11.016_bib85","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2025029507","article-title":"Improved diagnostic screening and classification of clonal mast cell diseases by ultrasensitive KIT p.D816V detection","author":"Navarro-Navarro","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2025.11.016_bib86","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/ced.15262","article-title":"Histopathological characteristics are instrumental to distinguish monomorphic from polymorphic maculopapular cutaneous mastocytosis in children","volume":"47","author":"Hermans","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib87","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/pde.13850","article-title":"Immunophenotype of pediatric-onset mastocytosis does not correlate with clinical course","volume":"36","author":"Greenberger","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib88","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-4939-1173-8_16","article-title":"Identification and immunophenotypic characterization of normal and pathological mast cells","volume":"1192","author":"Morgado","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jaip.2025.11.016_bib89","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajh.23672","article-title":"Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis","volume":"89","author":"Kristensen","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaip.2025.11.016_bib90","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jpeds.2012.08.035","article-title":"Imatinib mesylate in the treatment of diffuse cutaneous mastocytosis","volume":"162","author":"Morren","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaip.2025.11.016_bib91","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2025.11.016_bib92","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia: genotyping and associated clinical features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2025.11.016_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.716786","article-title":"Case report: hereditary alpha tryptasemia in children: a pediatric case series and a brief overview of literature","volume":"9","author":"Zama","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2025.11.016_bib94","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1016\/j.jaip.2019.05.032","article-title":"Treatment of systemic mastocytosis in an infant with midostaurin","volume":"7","author":"Liu","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.11.016_bib95","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jaip.2022.12.016","article-title":"Hematopoietic KIT D816Y mutation presenting as in utero aggressive systemic mastocytosis with response to midostaurin","volume":"11","author":"Voelker","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.11.016_bib96","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.10.020","article-title":"Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes","volume":"125","author":"Teodosio","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib97","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2340\/00015555-2325","article-title":"Multidisciplinary management of mastocytosis: Nordic Expert Group Consensus","volume":"96","author":"Broesby-Olsen","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2025.11.016_bib98","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.3390\/jcm11113153","article-title":"Drugs and vaccines hypersensitivity in children with mastocytosis","volume":"11","author":"Mori","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaip.2025.11.016_bib99","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/ACI.0000000000000869","article-title":"Updates in diagnosis and management of paediatric mastocytosis","volume":"23","author":"Tiano","year":"2023","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib100","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/pai.12762","article-title":"Vaccination and allergy: EAACI position paper, practical aspects","volume":"28","author":"Nilsson","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib101","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jaci.2018.10.063","article-title":"Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: a Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology","volume":"143","author":"Carter","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib102","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.anai.2023.09.015","article-title":"Anaphylaxis: a 2023 practice parameter update","volume":"132","author":"Golden","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib103","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaip.2019.02.002","article-title":"Mast cell activation syndrome and mastocytosis: initial treatment options and long-term management","volume":"7","author":"Castells","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.11.016_bib104","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.iac.2014.01.012","article-title":"Treatment strategies in mastocytosis","volume":"34","author":"Siebenhaar","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2025.11.016_bib105","doi-asserted-by":"crossref","DOI":"10.1111\/pde.70038","article-title":"Omalizumab for pediatric cutaneous mastocytosis: case report and review","author":"Chang","year":"2025","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib106","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/ced.13408","article-title":"Effective management of severe cutaneous mastocytosis in young children with omalizumab (Xolair((R)))","volume":"43","author":"Hughes","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2025.11.016_bib107","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.anai.2013.08.014","article-title":"Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis","volume":"111","author":"Matito","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.11.016_bib108","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13052-022-01402-7","article-title":"Successful treatment with omalizumab of a child affected by systemic mastocytosis: clinical and biological implications","volume":"49","author":"Bossi","year":"2023","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.jaip.2025.11.016_bib109","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200339","article-title":"Avapritinib versus placebo in indolent systemic mastocytosis","volume":"2","author":"Gotlib","year":"2023","journal-title":"NEJM Evid"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825011158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825011158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T16:25:48Z","timestamp":1768753548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825011158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2213219825011158"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.11.016","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Mastocytosis and Mast Cell Activation in Children","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}